Tag: drug development
Biotech Innovation Thrives Despite US Leadership Challenges, Industry Veteran Warns
Biotech industry delivers unprecedented breakthroughs while facing mounting challenges to US leadership from regulatory delays, funding constraints, and international competition.…
Prometheus Biotech Secures Record $12 Billion for AI-Powered Drug Development
Biotech startup Prometheus secures record $12 billion funding for AI-powered drug development platform. Investment represents largest single round for artificial…
New Drug Target for Alzheimer’s Shows Promise in Preclinical Studies
Researchers identified a novel Alzheimer's mechanism and developed an experimental compound that slowed nerve cell loss in mouse models. The…
China’s biotech reforms accelerate drug development and patient access
China's integration of national reforms with institutional redesign has accelerated drug development and improved patient access to medicines. Global momentum…
House cats’ cancer genetics reveal new treatment pathways for human breast cancer
A landmark study analyzing 495 cat tumors worldwide revealed 85% genetic similarity with human breast cancer. The research opens new…
Biogen-Denali Parkinson’s Drug Fails Phase 2 Trial, Highlighting Treatment Development Challenges
Biogen and Denali's experimental Parkinson's therapy failed Phase 2 trial endpoints, highlighting ongoing challenges in neurodegenerative disease drug development. The…
New R&D Ranking Reveals Sharp Disparities in Pharmaceutical Innovation Efficiency
A new evidence-based ranking of pharmaceutical companies reveals significant disparities in how efficiently firms convert R&D spending into drug approvals.…

